BCG Vaccine (Chengdu Ernst&Young Dingye Biotech)

卡介苗（成都安永鼎业生物）

Report date: 2026/04/28 20:00:22

Base Information

Drug NameBCG Vaccine (Chengdu Ernst&Young Dingye Biotech)

Drug Alias Name治疗用重组卡介苗

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChengdu Ernst&Young Dingye Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Ernst&Young Dingye Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsUrinary Bladder Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A